MRD-driven HDACi-based therapy post-transplant: a real-world study in high-risk acute myeloid leukemia.

Epidaza (chidamide) - Chipscreen

http://www.ncbi.nlm.nih.gov/pubmed/42439986

Chengwei Luo; Jianyu Weng; Jiaqi Tan; Jinghua Wang; Lisi Huang; Peilong Lai; Ping Wu; Ruohao Xu; Suijing Wu; Wei Ling; Xiaoling Liang; Xiaomei Chen; Xin Du; Zhilun Li

Jul 14, 2026